Two site-specific anti-peptide antisera have been produced that efficiently recognize the native form of the v-erb B protein from avian erythroblastosis virus(AEV)-infected chicken erythroblasts and fibroblasts, and from AEV-transformed mammalian cells. Since the antibodies were generated against synthetic sequences, the immunoprécipitations could be performed in the presence or absence of immunizing peptide, permitting the specifically precipitated proteins to be identified from background non-specifically adsorbed proteins. We confirmed that immobilized v-erb B protein from cell lysates of unlabelled AEV-infected chicken erythroblasts became labelled upon incubation with [y-32P]ATP. In addition we demonstrated for the first time that v-erb B from mammalian cells became labelled under the same conditions. These results suggest that the v-erb B protein may possess intrinsic kinase activity. The reagents described should permit further investigations as to whether this activity plays a role in maintaining cellular transformation.
INTRODUCTION
Avian erythroblastosis virus is an acutely transforming retrovirus that causes erythroleukaemia and sarcomas in chickens (Graf & Beug, 1978) . The ES4 and R strains of AEV contain the 5' region of the viral gag gene sequences followed by two acquired cellular genes, designated v-erb A and v-erb B, followed by the 3' portion of the viral env gene sequence (for a brief review, see Graf & Beug, 1983 ). The provirus is translated into a genome length mRNA, which encodes v-erb A and v-erb B, and also a subgenomic mRNA, which encodes some 5' sequences and the v-erb B sequence. The v-erb A protein includes some gajf-specified N-terminal amino acids and the v-erb B molecule (AEV-H) runs on to contain four ewf-specified amino acids at its C terminus. The v-erb A protein has an apparent molecular weight on sodium dodecyl sulphate/polyacrylamide (SD S/PAGE) gels of 75 000 and is found in the cytoplasm of AEV-infected cells. Recently, the viral erb A gene has been sequenced (Debuire et al. 1984 ). The predicted protein that it encodes consists of 398 amino acids with a calculated molecular weight of 45 400. The p75gag~erb A fusion protein however, has a predicted molecular weight of 72000, similar to that observed experimentally. Inspection of the sequence of v-erb A revealed that its C-terminal * Author to whom reprint requests should be addressed. 
RESULTS AND DISCUSSION
Several peptides from the sequence of the v-erb B protein were selected for synthesis ( Fig. 1 ). These were purified and then conjugated to keyhole limpet haemocyanin (K L H ) using glutaraldehyde in order to produce an immunogenic structure. Haemocyanin itself is a highly immunogenic molecule (Gullick, Head & Wood, 1981) , whereas immunization with short peptides rarely stimulates a humoral immune response. By attaching the peptides to the immunogenic carrier it is possible to obtain high-titre antibody mixtures that can react with both the carrier and the peptide (and also sometimes the cross-linking reagent). In such conjugates it is likely that the peptide becomes attached at many sites on the large (9 X 1 0 6 M r) hae mocyanin molecule. Such structures would exist in conformations influenced by the local surface residues of the carrier. T h e immune response stimulated would thus be quite varied and reflect the configurations of the peptide in such complexes. These would, however, not necessarily be the same as the conformation that the sequence assumes in the context of the native folded v-erb B molecule, particularly since all the sequences used in this work are bordered by contiguous amino acid sequences. (1985) . Track 1, preimmune serum; track 2, immune serum to peptide 2 E ; track 3, immunoprécipitation performed in the presence of competing peptide.
In order to ascertain whether such anti-peptide antibodies were produced it was necessary to distinguish anti-peptide response from the background of anti-carrier response. One simple and convenient method that achieves this is an E L IS A assay in which the peptide alone is passively adsorbed onto 96-well plastic tissue culture plates (Gullick et al. 1985a) . Animals immunized with each of the peptides de scribed in Fig. 1 produced antisera that gave a strongly positive reaction in E L IS A and were specific for the immunizing sequence (Gullick et al. 19856) . T h e anti-peptide sera were then tested for their ability to immunoprecipitate the v-erb B protein. Avian erythroblasts, infected with AEV E S 4 , were labelled with ['15S]m ethionine and then solubilized with Triton X -100. T h e antibodies to peptide 2E (K ris e t al. 1985) and peptide 15E were able to precipitate v-erb B protein efficiently (Fig. 2, tracks 3 and 5) from the cell lysate. T h e reaction was specific, by the criterion that including the immunizing peptide in excess over antibody inhibited the immunoprécipitation (Fig. 2, tracks 2 Kris et al. (1985) . Track 1, precipitation by antibodies to peptide 2 E ; track 2, immuno précipitation performed in the presence of competing peptide. T he arrow indicates the position of the v-erb B protein. Fig. 1 ) is just C-terminal to the 'protein kinase domain' shared (by definition) by the members of the src gene family. Peptide 15E (residues 160 -1 7 1 , Fig. 1 However, E G F receptor immobilized on antibodies to peptide 2E retained some ability to autophosphorylate and so these antibodies were used. Immunoprecipitates were pre pared, using preimmune serum, from unlabelled cell lysates of AEV-infected chicken erythroblasts, which, when run out on SDS/polyacrylamide gels contained some labelled proteins, but no material with the same molecular weight as v-erb B (Fig. 3, track 1). However, immunoprecipitates prepared with antibodies to peptide 2E gave strongly labelled material of the appropriate molecular weight (Fig. 3, track 2) , which was not present when the precipitation was performed in the presence of competing peptide (Fig. 3, track 3 (Fig. 4, track 1, arrowed) but was not present when the incubation was performed in the presence of competing peptide (Fig. 4, track 2 ).
Immunoprecipitates were then prepared from unlabelled lysates of AEV-trans formed rat fibroblasts using antibodies to peptide 2E. These were then incubated with [y-32P]ATP as described for AEV-infected erythroblast cell lysate. Immunoprecipitates from AC7b cells, which had previously been shown to contain the v-erb A protein (Quade et al. 1983) , contained 32P-labelled material with the predicted molecular weight of the v-erb B protein (Fig. 5, track 1, arrowed) , which was not present when the incubation was carried out in the presence of competing peptide (Fig. 5, track 2) .
These results indicate that antibodies to peptide 2E recognized the v-erb B protein from AEV-transformed chicken and rat fibroblasts and have permitted the first demonstration that the v-erb B protein, expressed in mammalian cells, becomes labelled with 32P in immunoprecipitates. We are currently using both of the antibody reagents described as immunoaffinity ligands to purify v-erb B and then to subject this material to a variety of physical separation techniques to determine more rigorously whether the v-erb B protein and the kinase activity copurify, and subse quently to establish whether the v-erb B kinase is constitutively activated. H a y m a n , M. J ., R a m s a y , G . M., S a v in , K . , K it c h e n e r , G ., G 
